References

1. Shimizu T. Behçet's syndrome-Lists of clinical and epidemical statistics. Nihon Rinsho. 1974 Jul 1; 32 Spec No: 2093-102. PubMed | Google Scholar


2. Kural-Seyahi E et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine. Baltimore. 2003 Jan; 82(1): 60-76. PubMed | Google Scholar


3. Zouboulis CC, Keitel W. A historical review of early descriptions of Adamantiades-Behçet's disease. J Invest Dermatol. 2002 Jul; 119(1): 201-5. PubMed | Google Scholar


4. Azizlerli G et al. Prevalence of Behçet's disease in Istanbul, turkey. Int J Dermatol. 2003 Oct; 42(10): 803-6. PubMed | Google Scholar


5. Onder M, Gurer MA. Behçet's disease: an enigmatic vasculitis. Clin Dermatol. 1999 Sep-Oct; 17(5): 571-6. PubMed | Google Scholar


6. Er H et al. Serum homocysteine level is increased and correlated with endotheilin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol. 2002 Jun; 86(6): 653-7. PubMed | Google Scholar


7. Saenz A et al. pharmacotherapy for Behçet's syndrome. Cochrane Database Syst Rev. 2000; (2): CD001084. PubMed | Google Scholar


8. Onder M, Gurer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereol. 2001 Mar; 15(2): 126-36. PubMed | Google Scholar


9. Direskeneli H. Behçet's diease: infectious aetiology, new auto-antigens, and HLA-B51. Ann Rheum Dis. 2001 Nov; 60(11): 996-1002. PubMed | Google Scholar


10. Ghate JV, Jorizzo JL. Behçet's disease and complex aphthosis. J Am Acad Dermatol. 1999 Jan; 40(1): 1-18 . PubMed | Google Scholar


11. Ozen S. Vasculopathy, Behçet's syndrome, and familial Mediterranean fever. Curr Opin Rheumatol. 1999 Sep; 11(5): 393-8. PubMed | Google Scholar


12. Tanaka T et al. Behçet's diease and antibody titers to various heat-shock protein-60s. Ocul Immunol Inflamm. 1999 Jun; 7(2): 69-74. PubMed | Google Scholar


13. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol. 2001 Feb; 37(2): 517-20. PubMed | Google Scholar


14. Wechsler B et al. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease. Ocul Immunol Inflamm. 2000 Dec; 8(4): 293-301. PubMed | Google Scholar


15. International Behçet's Study Group. Criteria for diagnosis of Behçet's disease. Lancet. 1990 May 5; 335(8697): 1078-80. PubMed | Google Scholar


16. Michelson JB, Chisari FV. Behçet's disease. Surv Ophthalmol. 1982 Jan-Feb; 26(4): 190-203. PubMed | Google Scholar


17. Atmaca LS. Fundus changes associated with Behçet's disease. Graefes Arch Clin Exp Ophthalmol. 1989; 227(4): 340-4. PubMed | Google Scholar


18. Palimeris G, Theodossiades G, Constantinidou B, Chimonidou E. La macula dans le syndrome d'Amandiades-Behçet. J Fr Ophtalmol. 1989; 12(12): 887-90. PubMed | Google Scholar


19. Nussenblatt RB. Macular alterations secondary to intraocular inflammatory disease. Ophthalmology. 1986 Jul; 93(7): 984-8. PubMed | Google Scholar


20. Bentley CR, Standford MR, Shilling JS, Sanders MD, Graham EM. Macular ischemia in posterior uveitis. Eye (Lond). 1993; 7(Pt 3): 411-4. PubMed | Google Scholar


21. Garcher C, Bielefeld P, Desvaux C, Besancenot JF, Bron A. Bilateral loss of vision and macular ischemia related to Behçet's disease. Am J Ophthalmol. 1997 Jul; 124(1): 116-7. PubMed | Google Scholar


22. Graham EM, Standford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with idiopathic retinal vasculitis: diagnostic value of ophtalmological features. Br J Ophthalmol. 1989 Sep; 73(9): 714-21. PubMed | Google Scholar


23. Mamo JG. The rate of visual loss in Behçet's disease. Arch Ophthalmol. 1970 Oct; 84(4): 451-2. PubMed | Google Scholar